lysergic acid diethylamide has been researched along with fluvoxamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Mjorndal, T; Spigset, O | 2 |
| Blier, P; De Montigny, C; Dong, J | 1 |
1 trial(s) available for lysergic acid diethylamide and fluvoxamine
| Article | Year |
|---|---|
The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Cell Membrane; Fluvoxamine; Humans; Kinetics; Lysergic Acid Diethylamide; Male; Prolactin; Receptors, Serotonin; Serotonin Receptor Agonists; Sodium; Water-Electrolyte Balance | 1997 |
4 other study(ies) available for lysergic acid diethylamide and fluvoxamine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.
Topics: Adult; Blood Platelets; Fluvoxamine; Humans; Lysergic Acid Diethylamide; Male; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Tritium | 1997 |
Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Electric Stimulation; Fluvoxamine; Hippocampus; Injections, Intravenous; Lysergic Acid Diethylamide; Male; Morpholines; Neurons; Piperazines; Prefrontal Cortex; Pyramidal Cells; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission | 1999 |